Ampio Pharmaceuticals, Inc. (AMPE)
OTCMKTS
· Delayed Price · Currency is USD
0.0021
0.00 (0.00%)
Feb 19, 2025, 3:00 PM EST
Ampio Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 4.09 | 12.65 | 33.89 | 17.35 | 6.53 | Upgrade
|
Short-Term Investments | 0.03 | 0.03 | 0.88 | 0.27 | 1.16 | Upgrade
|
Cash & Short-Term Investments | 4.12 | 12.69 | 34.78 | 17.61 | 7.69 | Upgrade
|
Cash Growth | -67.50% | -63.52% | 97.46% | 128.91% | 1.44% | Upgrade
|
Other Receivables | 0.92 | - | - | 0.19 | 0.02 | Upgrade
|
Receivables | 0.92 | - | - | 0.19 | 0.02 | Upgrade
|
Inventory | - | - | 0.07 | - | - | Upgrade
|
Prepaid Expenses | - | - | 0.24 | - | - | Upgrade
|
Other Current Assets | 0.69 | 0.64 | 0.55 | 0.7 | 0.54 | Upgrade
|
Total Current Assets | 5.74 | 13.33 | 35.63 | 18.49 | 8.25 | Upgrade
|
Property, Plant & Equipment | - | 0.26 | 3.19 | 4.39 | 5.75 | Upgrade
|
Total Assets | 5.74 | 13.59 | 38.83 | 22.88 | 14 | Upgrade
|
Accounts Payable | 0.75 | 0.1 | 0.43 | 0.19 | 0.15 | Upgrade
|
Accrued Expenses | 1.08 | 0.54 | 3.89 | 1.21 | 3.7 | Upgrade
|
Short-Term Debt | 0.18 | 0.19 | 0.27 | - | - | Upgrade
|
Current Portion of Leases | 0.27 | 0.34 | 0.31 | 0.28 | 0.26 | Upgrade
|
Other Current Liabilities | 0.1 | 0.03 | 0.22 | 0.15 | 0.18 | Upgrade
|
Total Current Liabilities | 2.38 | 1.19 | 5.12 | 1.83 | 4.28 | Upgrade
|
Long-Term Leases | - | 0.27 | 0.61 | 0.93 | 1.21 | Upgrade
|
Other Long-Term Liabilities | - | 0.33 | 5.81 | 2.61 | 2.06 | Upgrade
|
Total Liabilities | 2.38 | 1.8 | 11.54 | 5.37 | 7.56 | Upgrade
|
Common Stock | - | - | 0 | 0.02 | 0.02 | Upgrade
|
Additional Paid-In Capital | 245.89 | 245.73 | 244.88 | 218.02 | 191.06 | Upgrade
|
Retained Earnings | -242.53 | -233.94 | -217.6 | -200.53 | -184.63 | Upgrade
|
Total Common Equity | 3.36 | 11.79 | 27.28 | 17.51 | 6.44 | Upgrade
|
Shareholders' Equity | 3.36 | 11.79 | 27.28 | 17.51 | 6.44 | Upgrade
|
Total Liabilities & Equity | 5.74 | 13.59 | 38.83 | 22.88 | 14 | Upgrade
|
Total Debt | 0.45 | 0.8 | 1.19 | 1.21 | 1.47 | Upgrade
|
Net Cash (Debt) | 3.67 | 11.88 | 33.58 | 16.4 | 6.23 | Upgrade
|
Net Cash Growth | -69.10% | -64.61% | 104.73% | 163.50% | -17.93% | Upgrade
|
Net Cash Per Share | 4.53 | 15.77 | 49.15 | 28.47 | 14.24 | Upgrade
|
Filing Date Shares Outstanding | 1.14 | 0.76 | 0.76 | 0.65 | 0.53 | Upgrade
|
Total Common Shares Outstanding | 0.83 | 0.76 | 0.76 | 0.64 | 0.53 | Upgrade
|
Working Capital | 3.36 | 12.14 | 30.51 | 16.66 | 3.97 | Upgrade
|
Book Value Per Share | 4.03 | 15.61 | 36.01 | 27.17 | 12.18 | Upgrade
|
Tangible Book Value | 3.36 | 11.79 | 27.28 | 17.51 | 6.44 | Upgrade
|
Tangible Book Value Per Share | 4.03 | 15.61 | 36.01 | 27.17 | 12.18 | Upgrade
|
Machinery | - | 1.66 | 1.74 | - | - | Upgrade
|
Leasehold Improvements | - | 4.97 | 6.08 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.